Enbrel
Ailment: Rheumatoid Arthritis
U.S. Sales: $4.4 billion
Owner: Amgen
Enbrel provides symptomatic relief for rheumatoid arthritis patients, making it possible to eliminate chronic pain with ongoing treatment. The annual cost of the drug can exceed $20,000 per patient.
